A Review of the Serotonin-Norepinephrine Reuptake Inhibitors: Pharmacologic Aspects and Clinical Implications for Treatment of Major Depressive Disorder and Associated Painful Physical Symptoms

Journals Menu

Follow SCIRP

ISSN Print: 2169-9658
ISSN Online: 2169-9674
www.scirp.org/journal/ojd
E-mail: ojd@scirp.org

"A Review of the Serotonin-Norepinephrine Reuptake Inhibitors: Pharmacologic Aspects and Clinical Implications for Treatment of Major Depressive Disorder and Associated Painful Physical Symptoms"
written by Levent Alev, Alan Lenox-Smith, Murat Altin, Héctor Dueñas,
published by Open Journal of Depression, Vol.2 No.4, 2013

has been cited by the following article(s):

[1]	Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications
	2019

[2]	Recent Studies on Anti-Depressant Bioactive Substances in Selected Species from the Genera Hemerocallis and Gladiolus: A Systematic Review
	2019

[3]	Duloxetine: the pharmacological and clinical profile of a drug from the group of serotonin and noradrenaline reuptake inhibitors
	2018

[4]	Duloksetyna–profil farmakologiczny i kliniczny leku z grupy inhibitorów zwrotnego wychwytu serotoniny i noradrenaliny
	2018

[5]	Treatment of Pain with Antidepressants
	Klinik Psikofarmakoloji Bulteni, 2015

[6]	Biogenic Amines and the Amino Acids GABA and Glutamate: Relationships with Pain and Depression
	Pain in Psychiatric Disorders, 2015

[7]	Normas de prescrição e utilização racional de antidepressivos
	2015

[1]	Recent Studies on Anti-Depressant Bioactive Substances in Selected Species from the Genera Hemerocallis and Gladiolus: A Systematic Review Pharmaceuticals, 2019 DOI:10.3390/ph12040172

[2]	Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications Sexual Medicine Reviews, 2019 DOI:10.1016/j.sxmr.2018.12.003

[3]	Treatment of Pain with Antidepressants Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2015 DOI:10.5455/bcp.20150825014707

Follow SCIRP